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ABSTRACT 
Heterozygous APC germline alteration is responsible for familial adenomatous Polyposis, a 
colon cancer predisposition with almost complete penetrance. Point mutations generally lead 
to truncated proteins or no protein at all. They mainly involve exon 3 to codon 1700 (exon 
15). The work presented here precisely delineates the APC mutation spectrum through a 15-
years systematic molecular screening that identified 863 independent alterations in the French 
population. 
 
COMMUNICATION 
Familial adenomatous polyposis (FAP) is a well-described, autosomal dominant inherited 
syndrome with near complete penetrance associated with APC mutation.[1] The phenotypic 
hallmark of FAP is the presence of more than 100 colorectal adenomas in combination with 
extracolonic manifestations; a subset of APC mutation carriers presents with fewer colorectal 
adenomas, and, with the exception of desmoid tumors, lacks extradigestive manifestation. 
This variant disease has been initially referred to as “attenuated adenomatous polyposis coli” 
(AAPC) and more recently included in a clinical entity called “attenuated familial 
adenomatous polyposis” (AFAP).[2-3] We present here the genotypic description of 863 FAP 
patients who present with a germline APC genomic alteration. 
Patients referred from the French outpatient genetic clinics for molecular screening to 
document colonic adenomatous polyposis from 1993 and 2008 were systematically screened 
for point mutations of the APC gene from exon 3 to codon 1700 of exon 15. Negative cases 
exhibiting at least one extra-intestinal manifestation of FAP, as they were also negative for 
MYH mutations (data not shown), were selected for additional screening, including search for 
point mutations upstream of exon 3 and downstream of codon 1700 and large genomic 
rearrangements. All patients or legal representatives signed an informed consent for genetic 
analyses related to their disease. DNA was extracted from peripheral blood cells using 
standard procedure after cell lyses and proteinase K digestion. Several techniques of genomic 
analysis were successively applied and compared. Exons of the APC gene (NM_000038, 
NT033772.6) and splicing junctions were analyzed by sequencing after PCR amplification 
using primers reported by Groden et al.[4] Search for large genomic rearrangements was 
performed first applying the QMPSF (Quantitative Multiplex PCR of Short Fragments) 
technique. Results were validated and more precisely characterized by CGH on 244K 
oligoarrays (Agilent) and a 11,000-oligoarray specially designed, encompassing nucleotides 
111,999,686 to 112,306,766 from the chromosome 5 hg17 build. Exons were fully covered by 
overlapping and duplicated probes, with an average of one oligonucleotide every 12 bases. 
Introns and adjacent regions were covered with one oligonucleotide every 350 to 420 bases. 
Sequences analysis was driven using the PhredPhrapConsed package v11 and CGH data were 
analyzed with CGH-analytics® from Agilent Technologies. 
A total of 784 patients had variants predicted to shorten the length of the APC protein. The 
functional effect of variants observed in 48 additional patients was more ambiguous. In 
addition to in silico analysis, nucleotide substitutions were tested after PCR-amplification 
from patient genomic DNA together with approximately 150 bp of flanking sequences then 
inserted into a splicing reporter minigene according to Tournier et al.[5] Fifteen variants 
found in 22 patients had an impact on the splicing process and were subsequently classified as 
deleterious. The g.20,377,206A>T substitution located in exon 0.1, identified in 8 patients, 
cosegregated in two families with a cumulate LODscore of 5.6. A 40-bp deletion was also 
found in exon 0.1, that removed one splicing junction. Sixteen unique variants from 17 
patients remained unclassified, among which none occurred in highly conserved domains 
involved in beta-catenin binding or degradation.[6] 
Finally a total of 815 point mutations were retained to delineate the APC mutation spectrum, 
corresponding to 390 different mutations (Supplementary table 1, Figure 1). All will be 
referred to the APC mutation database developed with LOVD v2.0 Build 17, available at 
http://fap.taenzer.me/home.php?select_db=APC, where 91 are already described. All but 9 
mutations were located upstream to codon 1700 thus detected through the standard screening. 
No mutation was found in exons 1 and 2. Focussing on the 286 non-sense mutations, half 
(140) involved one of the 15 CGA codons leading within this part of gene (with the exception 
of codon 348 located in the alternatively transcribed part of exon 9), up to 25 times for codon 
213. The majority of insertions were duplications of one nucleotide. Most of the deletions 
involved short tandem repeats of 1 to 5 nucleotides. The two hot-spots described at codons 
1061 and 1309 were involved 56 and 92 times respectively., i.e. one third of the ins/del 
mutations. One larger deletion was found twice, also flanked by a 5-bp repeat. 
Large genomic deletions were detected by QMPSF in 48 patients, i.e. 5.5% of all germline 
alterations (Figure 1). No duplication was observed. All are also detected with the P043 
MLPA kit (MRC-Holland). Thirty-five deletions were studied on CGH arrays. All were 
confirmed on the dedicated array. Five deletions spanning exon 9 (2 cases) and 11 to 13 (3 
cases) were missed on the 244K array, no corresponding oligonucleotide being spotted on this 
array. The dedicated array allowed the characterization of the deletions boundaries, ranging 
from 2.7 Kb to over 17 Mb without any recurrent breakpoint as previously reported.[7] In two 
patients, the deletion of exons 11 to 13 was replaced with a 351-bp Alu Ya5 sequence. 
In a sub-group of 341 sporadic patients, parents’ DNAs were available and correct assignation 
of parentage was confirmed using Amp FlSTR SGM Plus kit (Applied Biosystems), so that it 
was clear that the mutation identified in the index case arose de novo. This means that at least 
40% of the detected pathogenic mutations arose as de novo mutations in the index case, a 
proportion slightly lower than that observed in other rare cancer predispositions, but much 
higher than that usually announced in familial adenomatosis polyposis (FAP).[8] 
A total of 863 genomic variants were identified through this systematic approach applied to 
patients exhibiting at least one extra-colonic common manifestation of FAP. No APC 
genomic alteration was found in 71 cases, leading to a 93% mutation detection rate in FAP. 
One allelic imbalance was noticed after RT-PCR but the causative genomic event could not 
be documented. As RNA was not available for the majority of patients, we could stipulate that 
this phenomenon is probably more frequent and could be investigated in relation to promoter 
hypermethylation or somatic mosaicism, as possible causes of FAP.[9,10] The presence of 
desmoid tumour was registered for 110 patients, i.e. 13% as commonly reported. 
In summary, this experience highlights the strong yield of APC germline mutations in familial 
adenomatous polyposis. The spectrum of mutations is wide from point mutations to large 
rearrangements, which can be complex. Finally, the high frequency of de novo mutations 
should be considered to propose APC screening in MutYH negative cases of sporadic 
adenomatous polyposis patients even in absence of extradigestive manifestations. 
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LEGEND TO FIGURE 1 
Figure 1: APC germline mutation spectrum 
The APC gene is represented from the 5’ genomic part on the left to the Stop codon on the 
right. Coding exons are shown in boxes. Introns are not dimensioned to scale. Vertical bars 
indicate mutations according to the number of events found independently; frequent events 
(more than 20) are countered next to the corresponding position Nucleotide substitutions 
within the coding sequence (in black) or involving consensus splicing regions (in grey), and 
short deletions/insertions are positioned above and under the exons respectively. Large 
genomic deletions are shown horizontally under the encompassed genomic region. 
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